Scispot, a leader in lab automation technology, announced the launch of Labflows, a next-generation lab interface designed to streamline sample-centric workflows in commercial and regulated labs. Tailored specifically for molecular diagnostics, genetic testing, molecular pathology, clinical genomics, infectious disease testing, and personalized medicine, Labflows empowers labs to execute end-to-end workflows with unmatched speed and precision.
Labflows is engineered to enhance every aspect of sample management—from registration through processing, analysis, and reporting. This innovative application within the Scispot platform provides a user-centric interface that consolidates all critical operations into a single intuitive dashboard. As the heart of Scispot’s alt-LIMS/LIS system, Labflows offers a comprehensive solution for labs that require fast, reliable, and fully traceable workflow execution.
“Labflows marks a significant step forward in lab automation,” said Satya Singh, President and CPO at Scispot. “By enabling lab operators to complete sample runs up to five times faster while ensuring full traceability and quality control, Labflows is setting a new benchmark for efficiency in labs.”
The introduction of Labflows brings a unified interface that simplifies workflow management, allowing lab operators to manage all stages of the sample lifecycle from one place. The design is user-friendly, reducing complexity and enabling technicians and scientists to move swiftly from sample registration to final report generation without unnecessary steps or delays. This end-to-end automation enhances productivity, ensuring that all data is connected, accurate, and fully traceable, eliminating manual errors and supporting compliance with stringent industry standards.
Also Read: GC Therapeutics: Scaling Next-Gen Cell Therapy
Labflows automates the integration of data from key instruments commonly used in diagnostics and research labs, including qPCR machines, next-generation sequencers (NGS), and automated liquid handlers. By seamlessly incorporating data from these instruments, Labflows facilitates automated analysis and reporting, speeding up workflows and reducing the potential for human error. The platform’s capability for automated pre-analysis and post-analysis quality control ensures that every sample meets rigorous standards before results are reported.
Furthermore, Labflows’ advanced capabilities allow labs to execute workflows up to five times faster, a critical advantage in high-demand environments where quick turnaround times are essential. By significantly reducing workflow execution times, Labflows enables labs to handle higher volumes of samples more efficiently, delivering faster results while maintaining the highest standards of quality and traceability.
Labflows is designed as a transformative solution to meet the growing demands of modern labs. Whether processing high-throughput genetic tests, managing complex molecular pathology workflows, conducting infectious disease screenings, or supporting personalized medicine initiatives, Labflows provides the speed, accuracy, and scalability that labs need to operate at peak performance.
SOURCE: PRWeb